All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior consent of the JoongAng Ilbo | Tel: 1577-0510
JoongAng Ilbo Co., Ltd. | Address: 48-6 Sangamsan-ro, Mapo-gu, Seoul, Republic of Korea
Business registration number: 110-81-00999 | CEO & Publisher: Park Chang-hee | Executive Editor: Choi Ji-young
Mail order business report number: 2020-Seoul Mapo-3838 | Online newspaper registration No: 서울,아55177
Date of Registration: 2023. 11. 21 | Juvenile Protection Manager: Park Hyunyoung
![Richard Lee, left, Lotte Biologics CEO, and Rainer Mueller, vice president of Roche CustomBiotech, pose for a photo during an agreement signing ceremony held in Penzberg, Germany. [LOTTE BIOLOGICS]](https://image.koreajoongangdaily.com/10201761.jpg?imageId=10201761&width=240&height=184&format=webp&format=jpg)
![Samsung Biologics’ third plant in Songdo, Incheon [SAMSUNG BIOLOGICS]](https://image.koreajoongangdaily.com/10650876.jpg?imageId=10650876&width=240&height=184&format=webp&format=jpg)
![Vegzelma, a Celltrion biosimilar of the anticancer drug Avastin [CELLTRION]](https://image.koreajoongangdaily.com/11733054.jpg?imageId=11733054&width=240&height=184&format=webp&format=jpg)
![Visitors crowd Samsung Biologics’ booth at the BIO International Convention (BIO USA) 2022 held in San Diego Monday. [SARAH CHEA]](https://image.koreajoongangdaily.com/10708994.jpg?imageId=10708994&width=240&height=184&format=webp&format=jpg)
![Molnupiravir, an oral Covid-19 treatment that is under development by MSD. [AP/YONHAP]](https://image.koreajoongangdaily.com/10435183.jpg?imageId=10435183&width=240&height=184&format=webp&format=jpg)